Novolog Pharm-Up 1966 Ltd Working Capital to Net Assets Ratio
Novolog Pharm-Up 1966 Ltd working capital to net assets ratio. Novolog Pharm-Up 1966 Ltd (NVLG) has a Working Capital to Net Assets ratio of -39.8% as of December 2025. Working capital of ILA-146.97 Million (current assets of ILA1.46 Billion minus current liabilities of ILA1.60 Billion) is measured against net assets of ILA368.90 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check NVLG goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Novolog Pharm-Up 1966 Ltd (2014–2025)
Working capital to net assets ratio of Novolog Pharm-Up 1966 Ltd from 2014 to 2025. This chart shows how Novolog Pharm-Up 1966 Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at -39.8%, reflecting working capital of ILA-146.97 Million against net assets of ILA368.90 Million ILA. See Novolog Pharm-Up 1966 Ltd (NVLG) liquidity interval to measure how many days the company can operate on defensive assets alone.
Novolog Pharm-Up 1966 Ltd Working Capital to Net Assets Ratio by Year (2014–2025)
Novolog Pharm-Up 1966 Ltd working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Novolog Pharm-Up 1966 Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see NVLG total asset value.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -39.8% | ILA-146.97 Million | ILA368.90 Million | ILA1.46 Billion | ILA1.60 Billion | ▼ -15.4 pp |
| 2024 | -24.5% | ILA-93.45 Million | ILA382.14 Million | ILA2.37 Billion | ILA2.46 Billion | ▼ -4.7 pp |
| 2023 | -19.8% | ILA-78.39 Million | ILA396.12 Million | ILA2.11 Billion | ILA2.18 Billion | ▼ -11.6 pp |
| 2022 | -8.2% | ILA-37.67 Million | ILA462.05 Million | ILA1.72 Billion | ILA1.76 Billion | ▼ -20.5 pp |
| 2021 | 12.3% | ILA52.94 Million | ILA430.23 Million | ILA1.74 Billion | ILA1.69 Billion | ▲ +21.0 pp |
| 2020 | -8.7% | ILA-25.64 Million | ILA295.67 Million | ILA1.71 Billion | ILA1.73 Billion | ▲ +5.8 pp |
| 2019 | -14.5% | ILA-38.12 Million | ILA263.78 Million | ILA1.68 Billion | ILA1.71 Billion | ▲ +48.9 pp |
| 2018 | -63.3% | ILA-64.37 Million | ILA101.61 Million | ILA1.53 Billion | ILA1.60 Billion | ▲ +16.3 pp |
| 2017 | -79.7% | ILA-68.27 Million | ILA85.71 Million | ILA1.62 Billion | ILA1.69 Billion | ▼ -52.2 pp |
| 2016 | -27.5% | ILA-19.44 Million | ILA70.68 Million | ILA1.42 Billion | ILA1.44 Billion | ▼ -62.1 pp |
| 2015 | 34.6% | ILA35.38 Million | ILA102.34 Million | ILA1.57 Billion | ILA1.54 Billion | ▲ +8.7 pp |
| 2014 | 25.8% | ILA22.42 Million | ILA86.77 Million | ILA1.25 Billion | ILA1.23 Billion | — |